Navidea Announces Manocept Study Results in Rheumatoid Arthritis to be Presented at EULAR '15 ECR
June 11, 2015 at 07:31 AM EDT
Navidea Biopharmaceuticals (NYSE: NAVB), announced that results from several pre-clinical Manocept™ studies in rheumatoid arthritis (RA) ...
